Seaside Ventures

Seaside Ventures is a venture capital and strategic investment firm focused on science-driven consumer health technologies within the global healthcare market, which they estimate at $4.5 trillion. The firm invests in early-stage and growth-stage startups that address root causes of health challenges, with a particular emphasis on proactive and preventative care—what they refer to as Medicine 3.0. Rather than functioning solely as a financial backer, Seaside Ventures positions itself as a hands-on strategic partner, offering operational support, go-to-market guidance, and growth infrastructure to the companies within its portfolio. The firm has accumulated over 27 years of combined experience and maintains relationships with more than 75 strategic partners, supporting a portfolio of 22 or more companies. Their investment thesis centers on mental and physical well-being, targeting innovations that can scale to improve the lives of over a billion people globally. Seaside Ventures structures its support model across four primary pillars: Foundations, which helps startups refine business models and optimize operations for commercial readiness; Go-To-Market, which assists founders in identifying target markets and executing commercialization strategies; Growth, which focuses on building strategic partnerships, expanding distribution, and scaling customer acquisition; and Visibility, which encompasses PR, branding, and market presence to help portfolio companies attract customers, investors, and talent. The firm is led by partners Harrison Valner and Ryan Roddy, who leverage their professional networks and industry expertise to guide founders through the complexities of scaling health technology businesses. Seaside Ventures bridges the gap between scientific validation and commercial success, transforming research-backed innovations into accessible, market-leading consumer health solutions. Their portfolio reflects a curated approach to investing, with each company selected based on its alignment with the firm's mission to revolutionize quality of life through cutting-edge health and wellness technologies. The firm operates at the intersection of healthcare, consumer products, and technology, making it relevant to CPG brands, health startups, and wellness innovators seeking both capital and strategic infrastructure.